{"id":7991,"date":"2025-10-30T23:02:59","date_gmt":"2025-10-30T23:02:59","guid":{"rendered":"https:\/\/mailitics.com\/index.php\/2025\/10\/30\/teladoc-when-will-things-look-better-health-tech-newsletter\/"},"modified":"2025-10-30T23:02:59","modified_gmt":"2025-10-30T23:02:59","slug":"teladoc-when-will-things-look-better-health-tech-newsletter","status":"publish","type":"post","link":"https:\/\/mailitics.com\/index.php\/2025\/10\/30\/teladoc-when-will-things-look-better-health-tech-newsletter\/","title":{"rendered":"STAT+: When will things look better for Teladoc?"},"content":{"rendered":"<p>    STAT+: When will things look better for Teladoc?<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n    <!-- no image --><br \/>\n \t<BR><br \/>\n<BR><\/BR><\/p>\n<div>\n<p>Y<em>ou\u2019re reading the web edition of STAT\u2019s Health Tech newsletter, our guide to how technology is transforming the life sciences.\u00a0<a href=\"https:\/\/www.statnews.com\/signup\/health-tech\/\">Sign up to get it<\/a>\u00a0delivered in your inbox every Tuesday and Thursday.<\/em><\/p>\n<p>From the beginning, it was evident that 2025 would be basically a throwaway year for Teldadoc\u2019s business as the virtual care giant aimed to stabilize\u00a0post-Covid. That reality was clear in <a href=\"http:\/\/ir.teladochealth.com\/news-and-events\/investor-news\/press-release-details\/2025\/Teladoc-Health-Reports-Third-Quarter-2025-Results\/default.aspx\" rel=\"noopener\">its quarterly earnings<\/a> that, as expected, showed a year-over-year revenue decline driven by the company\u2019s shrinking direct-to-consumer mental health company BetterHelp whose revenue was down 8% over the previous year. Teladoc this year made some strategic acquisitions and launched a new insurance covered and employer sponsored mental health offerings in hopes of setting itself up for future success. With Q3 on the books, analysts are starting to look ahead, and the initial takes are tepid.<\/p>\n<p>\u201cInto 2026, we expect only modest sequential improvement,\u201d wrote Evercore ISI\u2019s Elizabeth Anderson, adding: \u201cManagement commentary suggests another investment-heavy year, with operating leverage remaining limited until new offerings gain scale in late 2026 or 2027.\u201d<\/p>\n<p><a href=\"https:\/\/www.statnews.com\/2025\/10\/30\/teladoc-when-will-things-look-better-health-tech-newsletter\/?utm_campaign=rss\">Continue to STAT+ to read the full story\u2026<\/a><\/p>\n<\/div>\n<p> \t<BR><br \/>\n <BR><\/BR><br \/>\n    Mario Aguilar<br \/>\n \t<BR><br \/>\n<BR><\/BR><br \/>\n<a href=\"https:\/\/www.statnews.com\/2025\/10\/30\/teladoc-when-will-things-look-better-health-tech-newsletter\/?utm_campaign=rss\">Go to statnews<\/a><br \/>\n \t<BR><br \/>\n <BR><\/BR><\/p>\n","protected":false},"excerpt":{"rendered":"<p>STAT+: When will things look better for Teladoc? You\u2019re reading the web edition of STAT\u2019s Health Tech newsletter, our guide to how technology is transforming the life sciences.\u00a0Sign up to get it\u00a0delivered in your inbox every Tuesday and Thursday. From the beginning, it was evident that 2025 would be basically a throwaway year for Teldadoc\u2019s [&hellip;]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[69,2217,2318],"tags":[2150],"class_list":["post-7991","post","type-post","status-publish","format-standard","hentry","category-artificial-intelligence","category-health-tech","category-health-tech-newsletter","tag-statnews"],"_links":{"self":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7991"}],"collection":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/comments?post=7991"}],"version-history":[{"count":0,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/posts\/7991\/revisions"}],"wp:attachment":[{"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/media?parent=7991"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/categories?post=7991"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/mailitics.com\/index.php\/wp-json\/wp\/v2\/tags?post=7991"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}